Carla Castanaro

577 total citations
9 papers, 434 citations indexed

About

Carla Castanaro is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Carla Castanaro has authored 9 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Carla Castanaro's work include Lipid metabolism and disorders (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Carla Castanaro is often cited by papers focused on Lipid metabolism and disorders (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Carla Castanaro collaborates with scholars based in United States and Canada. Carla Castanaro's co-authors include Christopher Daly, Gavin Thurston, Elizabeth Pasnikowski, Nicholas Papadopoulos, George D. Yancopoulos, Alexander P. Adler, Alexandra Eichten, Alshad S. Lalani, Andrew I. Minchinton and Alastair H. Kyle and has published in prestigious journals such as Cancer Research, Oncogene and Scientific Reports.

In The Last Decade

Carla Castanaro

9 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carla Castanaro United States 6 245 159 102 100 73 9 434
Bingyin Shi China 14 389 1.6× 211 1.3× 72 0.7× 171 1.7× 66 0.9× 28 661
Daniela Morales-Espinosa Spain 12 206 0.8× 276 1.7× 56 0.5× 155 1.6× 190 2.6× 25 534
Matthew McCourt United Kingdom 9 171 0.7× 189 1.2× 141 1.4× 126 1.3× 56 0.8× 18 543
Andy Kaempf United States 12 181 0.7× 227 1.4× 135 1.3× 71 0.7× 138 1.9× 50 530
Maksim Yezhelyev Germany 7 245 1.0× 183 1.2× 48 0.5× 56 0.6× 61 0.8× 7 429
Nathalie Voorzanger‐Rousselot France 11 298 1.2× 278 1.7× 77 0.8× 87 0.9× 60 0.8× 13 545
Angel Qin United States 12 178 0.7× 343 2.2× 94 0.9× 122 1.2× 201 2.8× 33 561
Abdo Abou-Slaybi United States 3 174 0.7× 181 1.1× 61 0.6× 84 0.8× 66 0.9× 6 423
Greg Friberg United States 10 259 1.1× 189 1.2× 64 0.6× 95 0.9× 116 1.6× 15 488

Countries citing papers authored by Carla Castanaro

Since Specialization
Citations

This map shows the geographic impact of Carla Castanaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla Castanaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla Castanaro more than expected).

Fields of papers citing papers by Carla Castanaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carla Castanaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla Castanaro. The network helps show where Carla Castanaro may publish in the future.

Co-authorship network of co-authors of Carla Castanaro

This figure shows the co-authorship network connecting the top 25 collaborators of Carla Castanaro. A scholar is included among the top collaborators of Carla Castanaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carla Castanaro. Carla Castanaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Young, Tara M., Claudia Reyes, Elizabeth Pasnikowski, et al.. (2020). Autophagy protects tumors from T cell–mediated cytotoxicity via inhibition of TNFα-induced apoptosis. Science Immunology. 5(54). 79 indexed citations
2.
Daly, Christopher, Xiaozhong Qian, Carla Castanaro, et al.. (2018). Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor. Scientific Reports. 8(1). 505–505. 36 indexed citations
3.
Daly, Christopher, Carla Castanaro, Min Ni, et al.. (2016). FGFR3-TACC3 fusion proteins act as naturally occurring drivers of tumor resistance by functionally substituting for EGFR/ERK signaling. Oncogene. 36(4). 471–481. 48 indexed citations
4.
Zhang, Li, Carla Castanaro, Jeanette Fairhurst, et al.. (2014). ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models. Molecular Cancer Therapeutics. 13(5). 1345–1355. 42 indexed citations
5.
Daly, Christopher, Alexandra Eichten, Carla Castanaro, et al.. (2012). Angiopoietin-2 Functions as a Tie2 Agonist in Tumor Models, Where It Limits the Effects of VEGF Inhibition. Cancer Research. 73(1). 108–118. 180 indexed citations
7.
Lalani, Alshad S., Carla Castanaro, Alastair H. Kyle, et al.. (2011). Abstract A10: Combined blockade of VEGF and Ang2 promotes dramatic tumor necrosis and growth inhibition of colorectal cancer xenografts.. Molecular Cancer Therapeutics. 10(11_Supplement). A10–A10. 3 indexed citations
8.
Daly, Christopher, Carla Castanaro, Alexander P. Adler, et al.. (2011). Abstract 3290: REGN910, a fully-human, Ang2-specific monoclonal antibody, inhibits tumor growth as a monotherapy and dramatically potentiates the effects of VEGF Trap (aflibercept). Cancer Research. 71(8_Supplement). 3290–3290. 1 indexed citations
9.
Ciesielski, Michael J., Danuta Kozbor, Carla Castanaro, Tara A. Barone, & Robert A. Fenstermaker. (2008). Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma. Cancer Immunology Immunotherapy. 57(12). 1827–1835. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026